Infusion Options Recalls Velcade Syringes Due to Sterility Concerns
Infusion Options, Inc. is recalling various Velcade subcutaneous syringes in New York due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls.
Plain-English summary
Infusion Options, Inc. is recalling multiple strengths of Velcade subcutaneous syringes. The recall is being conducted because of a lack of assurance of sterility for the affected products.
The affected products include Velcade syringes in various milligram and milliliter concentrations, including 2.1 mg/0.84 ml, 2.5 mg/1 ml, 2.2 mg/0.88 ml, 2.6 mg/1.04 ml, 4 mg/1.6 ml, 2.75 mg/1.1 ml, 1.7 mg/0.68 ml, 3.5 mg/1.4 ml, 2.33 mg/0.93 ml, 2.4 mg/0.96 ml, and 2.63 mg/1.052 ml. The recall covers all lots within their expiration dates.
The distribution of these products was limited to New York. Consumers and healthcare providers should stop using the affected syringes and contact Infusion Options, Inc. for further instructions or a replacement.
The recalled product
- Product
- VELCADE 2.1 mg / 0.84 ml SQ SYRINGE; VELCADE 2.5 MG/ 1 ML SUB-Q SYRINGE; VELCADE 2.2 MG/ 0.88 ML SUB-Q SYRINGE; VELCADE 2.6 MG (1.04 ML) Sub Q SYRINGE; VELCADE 4 mg / 1.6 ml SQ SYRINGE; VELCADE 2.75 mg / 1.1 ml SQ SYRINGE; VELCADE 2.6 mg / 1.04 ml SQ SYRINGE VELCADE 1.7 mg…
- Manufacturer
- Infusion Options, Inc.
- Category
- Drug — Biologic / Oncology
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 76 recalled by Infusion Options, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 76 products in this recall →Related recalls
Same manufacturer · Infusion Options, Inc.
See all →- SevereInfusion Options Recalls Calcium Glucunate IV Bags Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- SevereInfusion Options Recalls Durvalumab Infusions Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- SevereInfusion Options Recalls Rituximab Infusions Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- SevereInfusion Options Recalls Fluorouracil Infusions Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- HighInfusion Options Recalls HERCEPTIN Infusions Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighMethadone Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighVancomycin Injectable Bags Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- HighNalbuphine Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-22
- SevereAssurance Infusion Recalls Fentanyl Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- SevereAssurance Infusion Recalls Phenol 2.5% Sterile Solution Due to Sterility Concerns
FDA (Drugs) · 2020-01-22
- HighFDA recalls Milrinone injectable medication due to lack of sterility assurance
FDA (Drugs) · 2023-02-22